| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.22▲ | 2.22▲ | 2.21▲ | 2.26▼ | 2.92▼ |
| MA10 | 2.21▲ | 2.20▲ | 2.21▲ | 2.49▼ | 3.32▼ |
| MA20 | 2.22▲ | 2.21▲ | 2.20▲ | 3.11▼ | 3.53▼ |
| MA50 | 2.20▲ | 2.23▼ | 2.39▼ | 3.35▼ | 3.16▼ |
| MA100 | 2.21▲ | 2.41▼ | 2.65▼ | 3.57▼ | 7.29▼ |
| MA200 | 2.21▲ | 2.69▼ | 3.37▼ | 3.11▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.006▲ | 0.018▲ | -0.096▼ | -0.119▼ |
| RSI | 57.342▲ | 52.265▲ | 46.222▼ | 30.216▼ | 37.420▼ |
| STOCH | 49.630 | 42.492 | 40.913 | 5.954▼ | 26.350 |
| WILL %R | -30.000 | -50.000 | -38.235 | -90.654▼ | -96.942▼ |
| CCI | 186.667▲ | 51.908 | 54.577 | -107.771▼ | -178.383▼ |
|
Monday, November 10, 2025 01:09 PM
Updated interim results from the Company’s [212Pb]VMT-α-NET Phase 1/2a study supporting the therapy’s compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025, ...
|
|
Friday, October 31, 2025 04:00 AM
Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today ...
|
|
Tuesday, October 28, 2025 10:58 AM
Detailed price information for Perspective Therapeutics Inc (CATX-A) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 2.25 | 2.30 | 2.16 | 2.22 | 2,301,500 |
| 07/11/25 | 2.18 | 2.28 | 2.12 | 2.19 | 1,604,800 |
| 06/11/25 | 2.31 | 2.34 | 2.17 | 2.23 | 2,847,408 |
| 05/11/25 | 2.34 | 2.4265 | 2.29 | 2.33 | 814,537 |
| 04/11/25 | 2.55 | 2.57 | 2.33 | 2.33 | 1,202,969 |
| 03/11/25 | 2.77 | 2.77 | 2.57 | 2.60 | 1,204,300 |
| 31/10/25 | 2.67 | 2.81 | 2.62 | 2.73 | 1,244,800 |
| 30/10/25 | 2.71 | 2.75 | 2.60 | 2.64 | 1,029,500 |
| 29/10/25 | 2.87 | 2.90 | 2.71 | 2.73 | 1,093,000 |
| 28/10/25 | 3.08 | 3.08 | 2.83 | 2.87 | 1,441,293 |
|
|
||||
|
|
||||
|
|